APTAMIR THERAPEUTICS INC has a total of 30 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are INTERNA TECH B V, LINEAGE CELL THERAPEUTICS INC and INTELLIA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Hong Kong | 3 | |
#6 | China | 2 | |
#7 | Australia | 1 | |
#8 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Thibonnier Marc | 29 |
Publication | Filing date | Title |
---|---|---|
WO2020051398A1 | Metabolic benefits of short mir-22 mirna antagomir therapies | |
WO2020010059A1 | Targeted delivery of therapeutic agents to human adipocytes | |
WO2017187426A1 | Inhibition of mir-22 mirna by apt-110 | |
EP2890789A1 | Mirna modulators of chronic visceral inflammation | |
WO2014022852A1 | Cell-specific delivery of mirna modulators for the treatment of obesity and related disorders | |
AU2013248981A1 | Mirna modulators of thermogenesis | |
US2013331433A1 | miRNA modulators of thermogenesis |